PRINT Trial (Platelet Rich Injection vs Needle Tenotomy)
NCT03504111 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2019-03-13
Summary
Chronic tendinopathy is often very difficult to treat and causes many patients who suffer from it to have significant pain and loss of function leading to disability. Ultrasound has been shown to be very effective in aiding in the diagnosis of soft tissue disorders including tendinopathy and can help to rule in or out other potential causes that may be confounders. Numerous methods have been tried to treat tendinopathy including rest, NSAIDs, bracing, physical therapy, extracorporal shock wave therapy, anesthetic injections, steroid injections, prolotherapy, nitro patches, surgery and more recently platelet rich plasma, all of which have had conflicting results in the literature. Platelet rich plasma (PRP) is an autologous blood product that contains a high concentration of platelet-derived growth factors that have the potential to enhance healing. In a study by Mishra et al, common extensor tenindosis showed improved pain symptoms (71% vs 55% at 24 weeks) with tenontomy combined with PRP compared to percutaneous needle tenontomy alone. Current studies show conflicting results as to whether PRP improves chronic tendinopathy when compared to steroid injections, and many do not have any control group or comparison group. Percutaneous needle tenotomy is the use of a large gauge needle (18 gauge), which may be performed under ultrasound guidance, to fenestrate repeatedly the area of tendinopathy within a tendon in order to disrupt tendinopathic tissue and to induce bleeding and clot formation with release of growth factors. To date there are no published studies comparing percutaneous needle tenotomy (PNT) alone vs. PRP without concomitant tenotomy. Current literature suggests that needle tenotomy may be superior but no head to head studies are currently found in the literature. Most of the published literature of non-operative treatment of tendinosis does not yield clearly designed trials with clear selection criteria. Current literature also lacks studies with significant number of patients that meet both clinical and ultrasound criteria thus previous studies lack sufficient power. The PRINT TRIAL: may enhance the understanding of a superior treatment if it exists.
Hypothesis: In active adults with chronic tendinopathy who have failed to respond to standard of care treatment, the use of ultrasound guided percutaneous needle tenotomy (PNT) alone is superior to PRP without concomitant tenotomy.
Conditions
- Lateral Epicondylitis
- Tendinosis
- Elbow, Tennis
- Elbows Tendonitis
Interventions
- PROCEDURE
-
Percutaneous Needle Tenotomy
A sham phlebotomy sample will be drawn on all study participants. Participants in this treatment group will be given local anesthesia with 1% lidocaine and then blinded to the intervention using a blind fold or shielding. Ultrasound guided needle tenontomy with be performed at the common extensor tendon at the area of tendinosis. There will be approximately 25 passes through the tendon with an 18 gauge needle. Investigators will keep track of the number of passes through the tendon. Investigators will keep track of the amount and type of anesthetic used to provide adequate and effective anesthesia
- PROCEDURE
-
PRP
A sham phlebotomy sample will be drawn on all study participants. Participants in this treatment group will be given local anesthesia with 1% lidocaine and then blinded to the intervention using a blind fold or shielding. Ultrasound guided injection of the PRP will be performed at the common extensor tendon at the area of tendinosis. Investigators will keep track of the amount and type of anesthetic used to provide adequate and effective anesthesia to the local skin
Sponsors & Collaborators
-
Kaiser Permanente
lead OTHER
Principal Investigators
-
Marissa S Vasquez, MD · Kaiser Permanente
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Platelet-Rich Plasma Therapy for Patellar Tendinopathy
NCT03136965 ·Status: COMPLETED ·Phase: PHASE2
-
Intraosseous PRP for Knee Osteoarthritis: Pilot Study
NCT03160781 ·Status: COMPLETED ·Phase: PHASE2
-
PEAK Platelet Rich Plasma Injection Treatment for Chronic Lateral Epicondylosis
NCT03072381 ·Status: COMPLETED ·Phase: PHASE2
-
Microfragmented Adipose Tissue Versus Platelet-rich Plasma for Knee Osteoarthritis: a Randomized Comparative Trial
NCT04351087 ·Status: COMPLETED ·Phase: NA
-
Intraosseous With Intra-articular Injection of Platelet Rich Plasma in Treatment of Knee Osteoarthritis
NCT03329235 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Validation of a Low-cost Platelet-Rich Plasma (PRP)
NCT06184048 ·Status: COMPLETED ·Phase: NA
-
PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT
NCT04937998 ·Status: RECRUITING ·Phase: NA
-
Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study.
NCT05660824 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Stromal Vascular Fraction (SVF) Injection in the Treatment of Patellar Tendinopathy
NCT04753853 ·Status: COMPLETED ·Phase: NA
-
Platelet Rich Plasma in Knee Osteoarthritis
NCT05080075 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effectiveness of Autologous Platelet-rich Plasma on Knee Cartilage Injury
NCT03024801 ·Status: COMPLETED ·Phase: NA
-
Comparing the Efficacy of Lyophilized Self Growth Factor Versus PRP Injection for Knee OA
NCT06932614 ·Status: RECRUITING ·Phase: NA
-
High Frequency Intensive Autologous PRP Injection and Genicular Nerve Blocks in Treating Knee Osteoarthritis
NCT04088045 ·Status: UNKNOWN ·Phase: NA
-
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
NCT05737173 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow)
NCT02861183 ·Status: WITHDRAWN ·Phase: NA
-
Microfracture With Platelet Rich Plasma Gel Injection for Osteochondral Lesion of the Talus
NCT06358807 ·Status: RECRUITING ·Phase: NA
-
How Does Platelet Dose Impact Clinical Outcomes After PRP Treatment?
NCT05330689 ·Status: WITHDRAWN ·Phase: PHASE2
-
Platelet-rich Plasma (PRP) vs Viscosupplementation for the Treatment of Early Knee Articular Degenerative Pathology
NCT02135367 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Genicular Nerve Block Prior to Radiofrequency Ablation for Knee Osteoarthritis Pain
NCT02578108 ·Status: COMPLETED ·Phase: NA
-
Platelet-rich Plasma Injections for Persistent Medial Knee Pain After Total Knee Arthroplasty
NCT03225092 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Platelet Rich Plasma (PRP) in Total Knee Replacement
NCT00826098 ·Status: COMPLETED ·Phase: PHASE4
-
Knee Arthritis Treatment With Autologous Fragmented Adipose Tissue and PRP - Comparison of Two Treatment Methods
NCT04321629 ·Status: UNKNOWN ·Phase: PHASE2
-
Recover L-PRP in Lateral Epicondylitis (REGP-11-00)
NCT02588040 ·Status: TERMINATED
-
Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement
NCT02920177 ·Status: TERMINATED ·Phase: PHASE4
-
Platelet Rich Plasma for Musculoskeletal Conditions
NCT07231471 ·Status: RECRUITING ·Phase: NA